Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20141
-
20142
Disparities in Hemoglobin A1c Testing During the Transition to Adulthood and Association With Diabetes Outcomes in Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes i...
Published 2021“…For type 2 diabetes, not seeing an endocrinologist decreased odds of reporting ≥3 HbA1c tests/year over time (OR 0.19 [0.06-0.63]), but HbA1c testing frequency was not associated with HbA1c levels or microvascular complications.…”
-
20143
-
20144
-
20145
Loss of Arid3b in Bone Marrow Results in Decreased B cells.
Published 2016“…<p>For analysis of hematopoietic populations by flow cytometry, bone marrow was harvested from <i>Arid3b</i><sup><i>fl/fl</i></sup>: <i>Mx1-Cre</i> (denoted Arid3b<sup>-/-</sup>) mice 12 weeks after final pIpC injection. <b>A)</b> Representative FACS plot of B cell (B220+) and myeloid populations (CD11b+) in control or arid3b<sup>-/-</sup> mice. …”
-
20146
-
20147
-
20148
-
20149
-
20150
-
20151
-
20152
-
20153
-
20154
BDNF exon IV-containing transcript is decreased following acute ZP treatment.
Published 2013“…<p>There is a selective and significant decrease in BDNF exon IV-containing transcript following ZP treatment compared to VEH in the HIP (n= 4-7). ** <i>p</i> < 0.01. …”
-
20155
N protein of SVCV decreases K48-linked ubiquitination of p53.
Published 2019“…<p><b>(A)</b> Effects of inhibitors on N protein-mediated destabilization of p53. …”
-
20156
Effect of dilution and DMSO concentration on the interaction of NF-κB/DNA complex with the inhibitors.
Published 2015“…<p><b>a)</b> Effect of 1) active compound <b>1</b>; 2) inactive compound <b>4</b>; B1) control complex NF-κB:DNA target and B2) free DNA target, at four different dilutions of the system: I) Initial conditions; II) Inhibitor at ¾, NF-κB at ¾ and DNA target to ½ of initial concentration; III) Diluting inhibitor to ½, NF-κB to ½ and DNA target to ¼ of initial concentration and IV) Diluting inhibitor at ½, NF-κB at ½ and DNA target at ¼ of initial concentration. …”
-
20157
-
20158
-
20159
-
20160